10.1182/blood-2013-02-485623 - Cytokine release syndrome after blina...

This document has been corrected

Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy

10.1182/blood-2013-02-485623

Published Online: 2013-06-27

Journal: Blood•Publisher: American Society of Hematology

Authors: Alix E. Seif•David M. Barrett•David T. Teachey•Erica K. Suppa•Gerhard Zugmaier•Julie C. Fitzgerald•Kim E. Nichols•Lia Gore•Michael Kalos•Richard Aplenc•Robert A. Berg•Shannon L. Maude•Stephan A. Grupp•Susan R. Rheingold

This document has been corrected

Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy

10.1182/blood-2013-02-485623

Published Online: 2013-06-27

Journal: Blood

NOW

2016-09-08•Erratum

Teachey DT, Rheingold SR, Maude SL, et al. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy. Blood. 2013;121(26):5154-5157.

10.1182/blood-2016-07-730671

* information provided by CrossRef

2016-09-08•Erratum

10.1182/blood-2016-07-730671

* information provided by CrossRef

2013-06-27•Published

2016-09-08•Erratum

10.1182/blood-2016-07-730671

* information provided by CrossRef

This document has been corrected

Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy

10.1182/blood-2013-02-485623

Published Online: 2013-06-27

Journal: Blood•Publisher: American Society of Hematology